The industry's main trade association, Pharmaceutical Research & Manufacturers of America, increased its spending by $930,750 to nearly $22.8 million.
Air transport is on pace to break its spending record this year, shelling out $79 million up from nearly $72 million this time last year.
Real estate also dropped off, spending less than $66 million, down from nearly $89 million this time last year, when the industry spent record lobbying numbers.
Overall lobbying spending is slightly down from last year, when it hit the highest level since 2010.
A major air ambulance firm called Air Medical Group Holdings spent $1.2 million in the third quarter alone over the same issue after not reporting lobbying for three years.
America's Health Insurance Plans, the top trade group for private insurers, ramped up its lobbying totals to $7.2 million from $5.2 million.
Huawei has increased its domestic lobbying spending 16-fold from this time last year, shelling out nearly $1.9 million to push back on a partial ban from the Trump administration.
https://www.opensecrets.org/news/2019/10/big-pharma-continues-to-top-lobbying-spending/
Air transport is on pace to break its spending record this year, shelling out $79 million up from nearly $72 million this time last year.
Real estate also dropped off, spending less than $66 million, down from nearly $89 million this time last year, when the industry spent record lobbying numbers.
Overall lobbying spending is slightly down from last year, when it hit the highest level since 2010.
A major air ambulance firm called Air Medical Group Holdings spent $1.2 million in the third quarter alone over the same issue after not reporting lobbying for three years.
America's Health Insurance Plans, the top trade group for private insurers, ramped up its lobbying totals to $7.2 million from $5.2 million.
Huawei has increased its domestic lobbying spending 16-fold from this time last year, shelling out nearly $1.9 million to push back on a partial ban from the Trump administration.
https://www.opensecrets.org/news/2019/10/big-pharma-continues-to-top-lobbying-spending/
No comments:
Post a Comment